orion corp (001800:Korea SE)
orion corp (001800) Snapshot
|
Open
1,068,000
|
Previous Close
1,068,000
|
|
|
Day High
1,078,000
|
Day Low
1,048,000
|
|
|
52 Week High
04/18/13 - 1,239,000
|
52 Week Low
08/17/12 - 814,000
|
|
|
Market Cap
6.3T
|
Average Volume 10 Days
16.8K
|
|
|
EPS TTM
29,180
|
Shares Outstanding
6.0M
|
|
|
EX-Date
12/27/12
|
P/E TM
36.2x
|
|
|
Dividend
3,000
|
Dividend Yield
0.28%
|
Related News
orion corp (001800) Related Businessweek News
No Related Businessweek News Foundorion corp (001800) Details
Orion Corporation engages in confectionery, entertainment, and sports businesses in South Korea and internationally. It produces and sells confectionery products, including pies, choco pie, chocolates, biscuits, gums, candies and jellies, snacks, and cookies primarily under the Orion Choco Pie, Goraebab, Cuttlefish Peanut Ball, Gosomi, and Choco Chip Cookie, and Choco Cluster brand names; whole wheat cake, crackers, rice chips, shrimp rice chips, and biscuits under the Dr.You brand name; and water cracker, bread chips, brownie, and baked potato fromage under the Market O brand name. The company also engages in the production, investment, and distribution of films; operates theaters under the MEGABOX brand name; and uses public funds raised through the Korean lottery in support of sports development under the Sports TOTO brand. In addition, it operates Orions, a basketball team; presents a range of cultural events, such as magic shows, quick-as-a-flash face mask changing, electronic string music, traditional Korean music, and sports dance; and operates the ‘Little Orions’, a youth basketball club, and a ‘Free Reserved Tickets for Children’ program that provides no-cost tickets to its home games to children who make a reservation in advance. The company was formerly known as Tong Yang Confectionery Corporation and changed its name to Orion Corporation in August 2003. Orion Corporation was founded in 1956 and is headquartered in Seoul, South Korea.
orion corp (001800) Key Developments
Orion Corporation is preparing to issue a EUR 100-150 million senior, unsecured bond that would mature in 5-7 years. The proceeds from the bond offering would be used for general corporate purposes.
Orion Corporation has submitted a marketing authorisation application for combined budesonide-formoterol formulation of the Easyhaler® product family in Europe. Orion applies for approval in European Union through decentralised procedure. The review process will commence once all involved member states have validated the application.
In its organising meeting, the Board of Directors of Orion Corporation, which was elected by the Annual Meeting of the Shareholders, has elected Jukka Ylppö as Vice Chairman.
| Recently Viewed | |||
| 001800:KS | 1,056,000.00 KRW | -12,000.00 | |
| Company | Last | Change | |
| No competitor information is available for 001800. | |||
| View Industry Companies | |||
Industry Analysis
001800
Industry Average
| Valuation | 001800 | Industry Range |
| Price/Earnings | 33.4x |
|
| Price/Sales | -- | Not Meaningful |
| Price/Book | 5.3x |
|
| Price/Cash Flow | 33.9x |
|
| TEV/Sales | 1.8x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact ORION CORP, please visit www.orionworld.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








